Care, Code & Choice

Patients. Clinicians. AI. Exploring trust, choice & the human side of healthcare AI, one real-world decision at a time. Independent & educational.

[Care, Code & Choice @CareCodeChoice]

Welcome to Care, Code & Choice.

Patients. Clinicians. AI.
We explore trust, transparency, real-world choices & the human side of healthcare AI.

What should happen next?

Independent & educational. Not medical advice.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 Green

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 That’s the right mindset for selling puts: pick a price you’d actually be comfortable owning the stock at.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 👍🏼

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 Understand it

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 $ORCL for me too. AI demand makes this one especially interesting.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 That’s the right filter. Premium gets attention, but owning the stock at the strike has to make sense first.

[Care, Code & Choice @CareCodeChoice]

@QualCompounders Hard to bet against that kind of growth.

[Care, Code & Choice @CareCodeChoice]

@QualCompounders Adobe feels like one of those names the market may be underestimating on AI.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 Rest is productive too.

[Care, Code & Choice @CareCodeChoice]

Sometimes the best thing a doctor can give a patient isn’t another test.

It’s a clear explanation.

[Care, Code & Choice @CareCodeChoice]

@Berci The real challenge isn’t whether AI scribes make mistakes. It’s designing the workflow so those mistakes are reliably caught before they reach the patient.

[Care, Code & Choice @CareCodeChoice]

@Shamsan_ha A tough result, but an important reminder: lowering a biomarker doesn’t automatically mean better clinical outcomes.

[Care, Code & Choice @CareCodeChoice]

@QualCompounders The business numbers keep improving while the stock tells a very different story. That disconnect is what makes $SOFI interesting.

[Care, Code & Choice @CareCodeChoice]

@InvestHarrison That $346 average is looking a lot better now. AVGO just needs to keep holding the post-earnings recovery.

[Care, Code & Choice @CareCodeChoice]

@_Warbucks1 That’s not a dip, that’s a cliff Now the question is whether the business broke or just the expectations did.

[Care, Code & Choice @CareCodeChoice]

@younweb3 Working hard matters. Learning how to make the same effort go further matters more.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 Pricing power might be one of the clearest signs of a real moat.

[Care, Code & Choice @CareCodeChoice]

AI is no longer just reading scans or suggesting diagnoses.
It’s starting to perform the procedure.

The line between assistance and automation is moving fast.

[Care, Code & Choice @CareCodeChoice]

@QualCompounders Big targets, but $META at $600 is probably the one I’d argue for the hardest.

[Care, Code & Choice @CareCodeChoice]

@TheQuietTrader1 That rebound did the heavy lifting. +77% on the put is a clean win.